Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus...

2

Transcript of Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus...

Page 1: Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus Eluting Stent System Polymer PI-GA 85/15 80 90 100 110 . Provides consistent, controlled
Page 2: Coronary Stents | Stent manufactures in India - Vascular · 2021. 5. 8. · eucaLimus Sirolimus Eluting Stent System Polymer PI-GA 85/15 80 90 100 110 . Provides consistent, controlled

2015-11-151 Biodegradable Polymer-Coated Sirolimus- Eluting Stent Implantation in AMI A Clinical and Angiographic Study General Hospital of Chinese People’s.

2015-11-151 Biodegradable Polymer-Coated Sirolimus- Eluting Stent Implantation in AMI A Clinical and Angiographic Study General Hospital of Chinese People’s.

Combo - A Combination Sirolimus Eluting Anti-CD34 Antibody …summitmd.com/pdf/pdf/2201_Rowland.pdf · 2012-05-15 · Antibody Coated Stent: Technology, Development & Clinical Data

Combo - A Combination Sirolimus Eluting Anti-CD34 Antibody …summitmd.com/pdf/pdf/2201_Rowland.pdf · 2012-05-15 · Antibody Coated Stent: Technology, Development & Clinical Data

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary

A new polymer-free drug-eluting stent with nanocarriers eluting sirolimus from stent-plus-balloon compared with bare-metal stent and with biolimus A9 eluting stent in porcine coronary

The Vascular Concepts - PRONOVA Durable Polymer ...The INdian NOVA Registry on Pronova Sirolimus Eluting Stent Innova Registry Commenced from – June 2005 The First Multi-center Registry

The Vascular Concepts - PRONOVA Durable Polymer ...The INdian NOVA Registry on Pronova Sirolimus Eluting Stent Innova Registry Commenced from – June 2005 The First Multi-center Registry

Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel- Eluting Stent for Coronary Lesions: The.

Comparison of the Efficacy and Safety of Zotarolimus-Eluting Stent versus Sirolimus-Eluting Stent and PacliTaxel- Eluting Stent for Coronary Lesions: The.

A Randomized Comparison of a Sirolimus-eluting Stent with Biodegradable Polymer versus an Everolimus-eluting Stent with a Durable Polymer for Percutaneous.

A Randomized Comparison of a Sirolimus-eluting Stent with Biodegradable Polymer versus an Everolimus-eluting Stent with a Durable Polymer for Percutaneous.

CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímero degradable

CENTURY: resultados clínicos del nuevo stent liberador de sirolimus y polímero degradable

Randomized Comparison of the Sirolimus Eluting Non ... · 1º Endpoint: Major Adverse Cardiac Events (Cardiac death, myocardial infarction, definite stent thrombosis, target vessel

Randomized Comparison of the Sirolimus Eluting Non ... · 1º Endpoint: Major Adverse Cardiac Events (Cardiac death, myocardial infarction, definite stent thrombosis, target vessel

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous.

Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous.

Original Article - SciELO · 2007-05-30 · Table 1 - Baseline estimates of the decision analytic model: procedural phase for bare-metal stent (BMS) and sirolimus-eluting stent (SES)

Original Article - SciELO · 2007-05-30 · Table 1 - Baseline estimates of the decision analytic model: procedural phase for bare-metal stent (BMS) and sirolimus-eluting stent (SES)

UvA-DARE (Digital Academic Repository) Dual-therapy stent ... · The bio-engineered COMBO stent has a dual-therapy strategy, which combines a sirolimus eluting coating with an anti-CD34

UvA-DARE (Digital Academic Repository) Dual-therapy stent ... · The bio-engineered COMBO stent has a dual-therapy strategy, which combines a sirolimus eluting coating with an anti-CD34

endoprothèse coronaire (stent) enrobée de Sirolimus ... · Le stent BIOSS LIM C libèrent progressivement le sirolimus jusqu’à 8 semaines au niveau de la paroi du vaisseau où

endoprothèse coronaire (stent) enrobée de Sirolimus ... · Le stent BIOSS LIM C libèrent progressivement le sirolimus jusqu’à 8 semaines au niveau de la paroi du vaisseau où

MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute myocardial infarction.

MULTIcentre evaluation of Single high-dose bolus TiRofiban versus Abciximab with sirolimus eluting sTEnt or bare metal stent in acute myocardial infarction.

ars.els-cdn.com · Web viewValues are shown as n (%). BP-BES, biodegradable polymer biolimus-eluting stent; BP-SES, biodegradable polymer sirolimus-eluting stent; CABG, coronary artery

ars.els-cdn.com · Web viewValues are shown as n (%). BP-BES, biodegradable polymer biolimus-eluting stent; BP-SES, biodegradable polymer sirolimus-eluting stent; CABG, coronary artery

PREPARE-CALC: A Randomized Trial of High-speed Rotational .../media/Clinical/PDF-Files/Approved-PDFs/2018… · Sirolimus-eluting Orsiro stent (Biotronik) Independent Clinical Event

PREPARE-CALC: A Randomized Trial of High-speed Rotational .../media/Clinical/PDF-Files/Approved-PDFs/2018… · Sirolimus-eluting Orsiro stent (Biotronik) Independent Clinical Event

eucaLimus - EUCATECH · eucaLimus. Sirolimus Eluting Coronary Stent System. Ultrathin 65 µm Design. Excellent Deliverability. Degradable Polymermatrix. Synchronized Polymerdegradation

eucaLimus - EUCATECH · eucaLimus. Sirolimus Eluting Coronary Stent System. Ultrathin 65 µm Design. Excellent Deliverability. Degradable Polymermatrix. Synchronized Polymerdegradation

Sirolimus ppt

Sirolimus ppt

BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,

BIOLIMUS-ELUTING STENT WITH BIODEGRADABLE POLYMER VERSUS SIROLIMUS-ELUTING STENT WITH DURABLE POLYMER: A RANDOMISED, NON-INFERIORITY TRIAL Stephan Windecker,

Randomised comparison of a sirolimus-eluting stent with a ...clintrialresults.org/Slides/Orsiro/SORT OUT-VII_Orsiro.pdfRandomized comparison of a sirolimus-eluting stent with a biolimus-eluting

Randomised comparison of a sirolimus-eluting stent with a ...clintrialresults.org/Slides/Orsiro/SORT OUT-VII_Orsiro.pdfRandomized comparison of a sirolimus-eluting stent with a biolimus-eluting

The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent Michael Haude, MD On behalf.

The REMEDEE Study: A Randomized Comparison of a Combination Sirolimus Eluting EPC Capture Stent with a Paclitaxel Eluting Stent Michael Haude, MD On behalf.